These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 27902989)

  • 1. Plasma Levels of Leptin and Adiponectin in Fragile X Syndrome.
    Lisik MZ; Gutmajster E; Sieroń AL
    Neuroimmunomodulation; 2016; 23(4):239-243. PubMed ID: 27902989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Levels of HDL in Fragile X Syndrome Patients.
    Lisik MZ; Gutmajster E; Sieroń AL
    Lipids; 2016 Feb; 51(2):189-92. PubMed ID: 26712713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome.
    Brasa S; Mueller A; Jacquemont S; Hahne F; Rozenberg I; Peters T; He Y; McCormack C; Gasparini F; Chibout SD; Grenet O; Moggs J; Gomez-Mancilla B; Terranova R
    Clin Epigenetics; 2016; 8():15. PubMed ID: 26855684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragile X syndrome.
    Saldarriaga W; Tassone F; González-Teshima LY; Forero-Forero JV; Ayala-Zapata S; Hagerman R
    Colomb Med (Cali); 2014; 45(4):190-8. PubMed ID: 25767309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNAs and Fragile X Syndrome.
    Lin SL
    Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CGG-repeat dynamics and
    Zhou Y; Kumari D; Sciascia N; Usdin K
    Mol Autism; 2016; 7():42. PubMed ID: 27713816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.
    Jacquemont S; Curie A; des Portes V; Torrioli MG; Berry-Kravis E; Hagerman RJ; Ramos FJ; Cornish K; He Y; Paulding C; Neri G; Chen F; Hadjikhani N; Martinet D; Meyer J; Beckmann JS; Delange K; Brun A; Bussy G; Gasparini F; Hilse T; Floesser A; Branson J; Bilbe G; Johns D; Gomez-Mancilla B
    Sci Transl Med; 2011 Jan; 3(64):64ra1. PubMed ID: 21209411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Validation of Fragile X Syndrome Screening by DNA Methylation Array.
    Schenkel LC; Schwartz C; Skinner C; Rodenhiser DI; Ainsworth PJ; Pare G; Sadikovic B
    J Mol Diagn; 2016 Nov; 18(6):834-841. PubMed ID: 27585064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragile X syndrome in females - a familial case report and review of the literature.
    Stembalska A; Łaczmańska I; Gil J; Pesz KA
    Dev Period Med; 2016; 20(2):99-104. PubMed ID: 27442693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening.
    Handt M; Epplen A; Hoffjan S; Mese K; Epplen JT; Dekomien G
    Mol Cell Probes; 2014; 28(5-6):279-83. PubMed ID: 25171808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic modifications in human fragile X pluripotent stem cells; Implications in fragile X syndrome modeling.
    Gerhardt J
    Brain Res; 2017 Feb; 1656():55-62. PubMed ID: 26475977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CGG Repeat-Induced FMR1 Silencing Depends on the Expansion Size in Human iPSCs and Neurons Carrying Unmethylated Full Mutations.
    Brykczynska U; Pecho-Vrieseling E; Thiemeyer A; Klein J; Fruh I; Doll T; Manneville C; Fuchs S; Iazeolla M; Beibel M; Roma G; Naumann U; Kelley N; Oakeley EJ; Mueller M; Gomez-Mancilla B; Bühler M; Tabolacci E; Chiurazzi P; Neri G; Bouwmeester T; Di Giorgio FP; Fodor BD
    Stem Cell Reports; 2016 Dec; 7(6):1059-1071. PubMed ID: 27840045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the extracellular signal-regulated kinase pathway contributes to the behavioral deficit of fragile x-syndrome.
    Wang X; Snape M; Klann E; Stone JG; Singh A; Petersen RB; Castellani RJ; Casadesus G; Smith MA; Zhu X
    J Neurochem; 2012 May; 121(4):672-9. PubMed ID: 22393900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-neuronal antibodies in patients with fragile X syndrome: is there a role of autoimmunity in its pathogenesis?
    Lisik MZ; Gutmajster E; Sieroń AL
    Neurodegener Dis; 2015; 15(1):45-9. PubMed ID: 25500855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Triplet expansion cytosine-guanine-guanine: Three cases of OMIM syndrome in the same family].
    González-Pérez J; Izquierdo-Álvarez S; Fuertes-Rodrigo C; Monge-Galindo L; Peña-Segura JL; López-Pisón FJ
    Med Clin (Barc); 2016 Apr; 146(7):311-5. PubMed ID: 26776484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.
    Taylor AK; Safanda JF; Fall MZ; Quince C; Lang KA; Hull CE; Carpenter I; Staley LW; Hagerman RJ
    JAMA; 1994 Feb; 271(7):507-14. PubMed ID: 8301764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of CGG repeat instability in germline cells from two male fetuses affected with fragile X syndrome].
    Duan R; Luo S; Huang W; Li H; Peng Y; Du Q; Wu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):606-9. PubMed ID: 27577204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced serum levels of pro-inflammatory chemokines in fragile X syndrome.
    Van Dijck A; Barbosa S; Bermudez-Martin P; Khalfallah O; Gilet C; Martinuzzi E; Elinck E; Kooy RF; Glaichenhaus N; Davidovic L
    BMC Neurol; 2020 Apr; 20(1):138. PubMed ID: 32295518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma cytokine profiles in Fragile X subjects: is there a role for cytokines in the pathogenesis?
    Ashwood P; Nguyen DV; Hessl D; Hagerman RJ; Tassone F
    Brain Behav Immun; 2010 Aug; 24(6):898-902. PubMed ID: 20102735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The psychiatric presentation of fragile x: evolution of the diagnosis and treatment of the psychiatric comorbidities of fragile X syndrome.
    Tranfaglia MR
    Dev Neurosci; 2011; 33(5):337-48. PubMed ID: 21893938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.